vs

Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and PAMT CORP (PAMT). Click either name above to swap in a different company.

COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $141.3M, roughly 1.5× PAMT CORP). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs -20.7%, a 29.0% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs -15.1%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $-25.0M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs -12.0%).

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.

COLL vs PAMT — Head-to-Head

Bigger by revenue
COLL
COLL
1.5× larger
COLL
$205.4M
$141.3M
PAMT
Growing faster (revenue YoY)
COLL
COLL
+28.1% gap
COLL
12.9%
-15.1%
PAMT
Higher net margin
COLL
COLL
29.0% more per $
COLL
8.3%
-20.7%
PAMT
More free cash flow
COLL
COLL
$147.3M more FCF
COLL
$122.4M
$-25.0M
PAMT
Faster 2-yr revenue CAGR
COLL
COLL
Annualised
COLL
19.1%
-12.0%
PAMT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
COLL
COLL
PAMT
PAMT
Revenue
$205.4M
$141.3M
Net Profit
$17.0M
$-29.3M
Gross Margin
62.5%
Operating Margin
29.6%
-27.0%
Net Margin
8.3%
-20.7%
Revenue YoY
12.9%
-15.1%
Net Profit YoY
35.3%
7.4%
EPS (diluted)
$0.48
$-1.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COLL
COLL
PAMT
PAMT
Q4 25
$205.4M
$141.3M
Q3 25
$209.4M
$150.3M
Q2 25
$188.0M
$151.1M
Q1 25
$177.8M
$155.3M
Q4 24
$181.9M
$166.5M
Q3 24
$159.3M
$182.6M
Q2 24
$145.3M
$182.9M
Q1 24
$144.9M
$182.6M
Net Profit
COLL
COLL
PAMT
PAMT
Q4 25
$17.0M
$-29.3M
Q3 25
$31.5M
$-5.6M
Q2 25
$12.0M
$-9.6M
Q1 25
$2.4M
$-8.1M
Q4 24
$12.5M
$-31.6M
Q3 24
$9.3M
$2.4M
Q2 24
$19.6M
$-2.9M
Q1 24
$27.7M
$281.0K
Gross Margin
COLL
COLL
PAMT
PAMT
Q4 25
62.5%
Q3 25
61.7%
Q2 25
57.7%
Q1 25
54.8%
Q4 24
54.0%
Q3 24
60.8%
Q2 24
62.5%
Q1 24
63.1%
Operating Margin
COLL
COLL
PAMT
PAMT
Q4 25
29.6%
-27.0%
Q3 25
29.7%
-3.8%
Q2 25
18.7%
-7.3%
Q1 25
12.2%
-5.9%
Q4 24
20.9%
-22.6%
Q3 24
21.9%
1.3%
Q2 24
32.7%
-0.4%
Q1 24
34.1%
-0.4%
Net Margin
COLL
COLL
PAMT
PAMT
Q4 25
8.3%
-20.7%
Q3 25
15.0%
-3.7%
Q2 25
6.4%
-6.4%
Q1 25
1.4%
-5.2%
Q4 24
6.9%
-19.0%
Q3 24
5.9%
1.3%
Q2 24
13.5%
-1.6%
Q1 24
19.1%
0.2%
EPS (diluted)
COLL
COLL
PAMT
PAMT
Q4 25
$0.48
$-1.38
Q3 25
$0.84
$-0.27
Q2 25
$0.34
$-0.46
Q1 25
$0.07
$-0.37
Q4 24
$0.36
$-1.44
Q3 24
$0.27
$0.11
Q2 24
$0.52
$-0.13
Q1 24
$0.71
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COLL
COLL
PAMT
PAMT
Cash + ST InvestmentsLiquidity on hand
$386.7M
$83.7M
Total DebtLower is stronger
$333.9M
Stockholders' EquityBook value
$301.7M
$210.5M
Total Assets
$1.7B
$697.9M
Debt / EquityLower = less leverage
1.59×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COLL
COLL
PAMT
PAMT
Q4 25
$386.7M
$83.7M
Q3 25
$285.9M
$115.6M
Q2 25
$222.2M
$117.3M
Q1 25
$197.8M
$102.7M
Q4 24
$162.8M
$110.7M
Q3 24
$120.0M
$92.3M
Q2 24
$271.6M
$114.0M
Q1 24
$318.0M
$125.8M
Total Debt
COLL
COLL
PAMT
PAMT
Q4 25
$333.9M
Q3 25
Q2 25
Q1 25
Q4 24
$325.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
COLL
COLL
PAMT
PAMT
Q4 25
$301.7M
$210.5M
Q3 25
$274.8M
$239.5M
Q2 25
$232.2M
$244.9M
Q1 25
$234.4M
$269.6M
Q4 24
$228.8M
$277.5M
Q3 24
$234.3M
$308.9M
Q2 24
$216.6M
$306.7M
Q1 24
$222.2M
$314.6M
Total Assets
COLL
COLL
PAMT
PAMT
Q4 25
$1.7B
$697.9M
Q3 25
$1.6B
$715.2M
Q2 25
$1.6B
$707.9M
Q1 25
$1.6B
$712.6M
Q4 24
$1.7B
$741.7M
Q3 24
$1.6B
$756.7M
Q2 24
$1.1B
$733.5M
Q1 24
$1.1B
$746.4M
Debt / Equity
COLL
COLL
PAMT
PAMT
Q4 25
1.59×
Q3 25
Q2 25
Q1 25
Q4 24
1.17×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COLL
COLL
PAMT
PAMT
Operating Cash FlowLast quarter
$123.0M
$-5.8M
Free Cash FlowOCF − Capex
$122.4M
$-25.0M
FCF MarginFCF / Revenue
59.6%
-17.7%
Capex IntensityCapex / Revenue
0.3%
13.6%
Cash ConversionOCF / Net Profit
7.25×
TTM Free Cash FlowTrailing 4 quarters
$327.6M
$-23.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COLL
COLL
PAMT
PAMT
Q4 25
$123.0M
$-5.8M
Q3 25
$78.4M
$5.9M
Q2 25
$72.4M
$12.2M
Q1 25
$55.4M
$5.0M
Q4 24
$84.6M
$15.2M
Q3 24
$-9.0M
$15.5M
Q2 24
$67.4M
$18.7M
Q1 24
$61.9M
$9.6M
Free Cash Flow
COLL
COLL
PAMT
PAMT
Q4 25
$122.4M
$-25.0M
Q3 25
$78.3M
$2.5M
Q2 25
$72.4M
$5.9M
Q1 25
$54.6M
$-6.8M
Q4 24
$84.1M
$-39.9M
Q3 24
$-9.2M
$-33.6M
Q2 24
$67.1M
$4.1M
Q1 24
$61.4M
$-12.2M
FCF Margin
COLL
COLL
PAMT
PAMT
Q4 25
59.6%
-17.7%
Q3 25
37.4%
1.7%
Q2 25
38.5%
3.9%
Q1 25
30.7%
-4.4%
Q4 24
46.2%
-24.0%
Q3 24
-5.8%
-18.4%
Q2 24
46.2%
2.2%
Q1 24
42.3%
-6.7%
Capex Intensity
COLL
COLL
PAMT
PAMT
Q4 25
0.3%
13.6%
Q3 25
0.1%
2.3%
Q2 25
0.0%
4.2%
Q1 25
0.4%
7.6%
Q4 24
0.3%
33.1%
Q3 24
0.2%
26.9%
Q2 24
0.2%
8.0%
Q1 24
0.4%
12.0%
Cash Conversion
COLL
COLL
PAMT
PAMT
Q4 25
7.25×
Q3 25
2.49×
Q2 25
6.05×
Q1 25
22.92×
Q4 24
6.75×
Q3 24
-0.96×
6.44×
Q2 24
3.44×
Q1 24
2.23×
34.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

COLL
COLL

Segment breakdown not available.

PAMT
PAMT

Freight Transportation Service$123.1M87%
Fuel Surcharge$18.2M13%

Related Comparisons